2005Unpublished venueRequires access

Correlation between nuclear factor kappaB activation and prognosis in patients with systemic inflammatory response syndrome

Shusheng Li

Open publisher page 0 citations

Abstract

Objective To observe the changes of nuclear factor Kappa B (NF-κB), interleukin-6 (IL-6)and acute physiology and chronic health evaluationⅡ (APACHEⅡ) scores in patients with systemic inflammatory response syndrome(SIRS), and to study the role of NF-κB in estimating the severity of illness and prognosis.Methods Thirty five patients in the intensive care unit (ICU) were in the trial group, and 20 healthy people were in the control group. Thirty five patients were divided into multiple organ dysfunction syndrome (MODS) group and non - MODS group according to the MODS diagnostic criterion, and they also were followed-up for 28 days and then assigned to the group of survivors and non - survivors based on their prognosis. The activation of NF-κB was measured by immunohistochemical method, and the level of IL-6 were examined by enzyme-linked immunosorbent assay(ELISA) in each patient at 1, 3,the 5 and 7 days. APACHEⅡ scores were calculated for each patient during the first 24h in the ICU.Results The activations of NF-κB and the level of IL-6 in patients with SIRS were higher than those in control group (P0.01). The activations of NF-κB, the level of IL-6 and APACHEⅡ scores in the MODS group and the non - survivors group were higher than those in non - MODS group and the survivors group (P0.01 or P0.05). There were obvious positive correlations between the activations of NF-κB and the level of IL-6 and APACHEⅡscores (r=0.754,r=0.737,respectively, P0.01), and also good positive correlation between the level of IL-6 and APACHEⅡscores (r= 0.635,P0.01). Conclusion The activation of NF-κB has a close relationship with the severity and the prognosis in patients with SIRS.

About this research paper

What this paper is about

Objective To observe the changes of nuclear factor Kappa B (NF-κB), interleukin-6 (IL-6)and acute physiology and chronic health evaluationⅡ (APACHEⅡ) scores in patients with systemic inflammatory response syndrome(SIRS), and to study the role of NF-κB in estimating the severity of illness and prognosis.Methods Thirty five patients in the intensive care unit (ICU) were in the trial group, and 20 healthy people were in the control group. Thirty five patients were divided into multiple organ dysfunction syndrome (MODS) group and non - MODS group according to the MODS diagnostic criterion, and they also were followed-up for 28 days and then assigned to the group of survivors and non - survivors based on their prognosis. The activation of NF-κB was measured by immunohistochemical method, and the level of IL-6 were examined by enzyme-linked immunosorbent assay(ELISA) in each patient at 1, 3,the 5 and 7 days. APACHEⅡ scores were calculated for each patient during the first 24h in the ICU.Results The activations of NF-κB and the level of IL-6 in patients with SIRS were higher than those in control group (P0.01). The activations of NF-κB, the level of IL-6 and APACHEⅡ scores in the MODS group and the non - survivors group were higher than those in non - MODS group and the survivors group (P0.01 or P0.05). There were obvious positive correlations between the activations of NF-κB and the level of IL-6 and APACHEⅡscores (r=0.754,r=0.737,respectively, P0.01), and also good positive correlation between the level of IL-6 and APACHEⅡscores (r= 0.635,P0.01). Conclusion The activation of NF-κB has a close relationship with the severity and the prognosis in patients with SIRS.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the changes of nuclear factor Kappa B (NF-κB), interleukin-6 (IL-6)and acute physiology and chronic health evaluationⅡ (APACHEⅡ) scores in patients with systemic inflammatory response syndrome(SIRS), and to study the role of NF-κB in estimating the severity of illness and prognosis.Methods Thirty five patients in the intensive care unit (ICU) were in the trial group, and 20 healthy people were in the control group. Thirty five patients were divided into multiple organ dysfunction syndrome (MODS) group and non - MODS group according to the MODS diagnostic criterion, and they also were followed-up for 28 days and then assigned to the group of survivors and non - survivors based on their prognosis. The activation of NF-κB was measured by immunohistochemical method, and the level of IL-6 were examined by enzyme-linked immunosorbent assay(ELISA) in each patient at 1, 3,the 5 and 7 days. APACHEⅡ scores were calculated for each patient during the first 24h in the ICU.Results The activations of NF-κB and the level of IL-6 in patients with SIRS were higher than those in control group (P0.01). The activations of NF-κB, the level of IL-6 and APACHEⅡ scores in the MODS group and the non - survivors group were higher than those in non - MODS group and the survivors group (P0.01 or P0.05). There were obvious positive correlations between the activations of NF-κB and the level of IL-6 and APACHEⅡscores (r=0.754,r=0.737,respectively, P0.01), and also good positive correlation between the level of IL-6 and APACHEⅡscores (r= 0.635,P0.01). Conclusion The activation of NF-κB has a close relationship with the severity and the prognosis in patients with SIRS.

Key concepts: Medicine, Multiple organ dysfunction syndrome, APACHE II, Intensive care unit, Systemic inflammatory response syndrome, Internal medicine, Group B, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
Correlation between nuclear factor kappaB activation and prognosis in patients with systemic inflammatory response syndrome — Research Paper | ScholarLens